Clinical trial
Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be…
NCT00293501 · University of Vermont, Other · Unknown status
Key facts
| NCT number | NCT00293501 |
|---|---|
| Title | Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery |
| Official title | A Phase I/II Trial of Tinzaparin (Innohep), a Low Molecular Weight Heparin (LMWH) for Treatment of Advanced Renal Cell Carcinoma |
| Lead sponsor | University of Vermont, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Unknown status |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Drug |
| Interventions | tinzaparin sodium |
| Enrollment | 35 |
| Start date | Dec 1, 2005 |
| Primary completion | Feb 1, 2007 |
| First posted | Feb 17, 2006 |
| Last update posted | Nov 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: